IL6 and metabolic dysfunction-associated steatotic liver disease: Additionally, omega-3 supplementation did not improve IL-6 levels in Metabolic dysfunction-associated steatotic liver disease (MASLD) patients (MD = 0.00, <i>p</i> > 0.05).